Norepinephrine transporter function and orthostatic syndromes

Journal of Functional Syndromes

Volumn 2, Issue 1, 2002, Pages 3-8

  Schroeder, C ^a   Tank, J ^a   Luft, F C ^a   Jordan, Jens ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Norepinephrine transporter; Orthostatic intolerance; Orthostatic syndromes; Syncope

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; NORADRENALIN; NORADRENALIN TRANSPORTER;

ADRENERGIC ACTIVITY; ADRENERGIC STIMULATION; CLINICAL FEATURE; DISEASE ASSOCIATION; FUNCTIONAL DISEASE; HEART STIMULATION; HUMAN; IDIOPATHIC DISEASE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SYMPTOMATOLOGY; SYNCOPE; TACHYCARDIA; VASCULARIZATION;

EID: 0012740423     PISSN: 15910989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Furlan R. Functional Abnormalities of Neural Autonomic Control in Chronic Orthostatic Intolerance. Journal of Functional Syndromes 2001; 1 2-3): 171-5.
2. Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R. The Elusive Pathophysiology of Neurally Mediated Syncope. Circulation 5-12-2000; 102 (23): 2898-906.
3. Jordan J, Shannon J, Robertson D. The Physiological Conundrum of Hyperadrenergic Orthostatic Intolerance. Chin J Physiol 1997; 40 (1): 1-8.
4. Lundberg JM. Pharmacology of Cotransmission in the Autonomic Nervous System: Integrative Aspects on Amines, Neuropeptides, Adenosine Triphosphate, Amino Acids and Nitric Oxide. Pharmacol Rev 1996; 48 (1): 113-78.
5. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of Catecholamine Neurotransmitters to the Circulation: Source, Fate, and Functions. Physiol Rev 1990; 70 (4): 963-85.
6. Robertson D, Flattem N, Tellioglu T, Carson R, Garland E, Shannon JR, Jordan J, Jacob G, Blakely RD, Biaggioni I. Familial Orthostatic Tachycardia Due to Norepinephrine Transporter Deficiency. Ann NY Acad Sci 2001; 940: 527-43.
7. Figlewicz DP. Endocrine Regulation of Neurotransmitter Transporters. Epilepsy Res 1999; 37 (3): 203-10.
8. Pacholczyk T, Blakely RD, Amara SG. Expression Cloning of a Cocaine- and Antidepressant-Sensitive Human Noradrenaline Transporter. Nature 28-3-1991; 350 (6316): 350-4.
9. Blakely RD, De-Felice LJ, and Hartzell HC. Molecular Physiology of Norepinephrine and Serotonin Transporters. J Exp Biol 1994; 196263-81:-81.
10. Olivier B, Soudijn W, van Wijngaarden I. Serotonin, Dopamine and Norepinephrine Transporters in the Central Nervous System and Their Inhibitors. Prog Drug Res 2000; 5459-119:-119.
11. Galli A, Blakely RD, DeFelice LJ. Norepinephrine Transporters Have Channel Modes of Conduction. Proc Natl Acad Sci USA 6-8-1996; 93 (16): 8671-6.
12. Boyd FT, Clarke DW, Muther TF, Raizada MK. Insulin Receptors and Insulin Modulation of Norepinephrine Uptake in Neuronal Cultures From Rat Brain. J Biol Chem 15-12-1985; 260 (29): 15880-4.
13. Figlewicz DP, Szot P, Israel PA, Payne C, Dorsa DM. Insulin Reduces Norepinephrine Transporter MRNA in Vivo in Rat Locus Coeruleus. Brain Res 29-1-1993; 602 (1): 161-4.
14. Tejani-Butt SM, Yang J. A Time Course of Altered Thyroid States on the Noradrenergic System in Rat Brain by Quantitative Autoradiography. Neuroendocrinology 1994; 59 (3): 235-44.
15. Yang SP, Pau KY, Spies HG. Gonadectomy Alters Tyrosine Hydroxylase and Norepinephrine Transporter MRNA Levels in the Locus Coeruleus in Rabbits. J Neuroendocrinol 1997; 9 (10): 763-8.
16. Yang SP, Pau KY, Spies HG. Tyrosine Hydroxylase and Norepinephrine Transporter MRNA Levels Increase in Locus Coeruleus After Coitus in Rabbits. J Mol Endocrinol 1997; 19 (3): 311-9.
17. Heritage AS, Stumpf WE, Sar M, Grant LD. Brainstem Catecholamine Neurons Are Target Sites for Sex Steroid Hormones. Science 21-3-1980; 207 (4437): 1377-9.
18. Ali YS, Daamen N, Jacob G, Jordan J, Shannon JR, Biaggioni, I, Robertson D. Orthostatic Intolerance: a Disorder of Young Women. Obstet Gynecol Surv 2000; 55 (4): 251-9.
19. Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I, Luft FC, Jordan J. Selective Norepinephrine Reuptake Inhibition As a Human Model of Orthostatic Intolerance. Circulation 22-1-2002; 105 (3): 347-53.
20. Kahan T, Hjemdahl P, Dahlof C. Relationship Between the Overflow of Endogenous and Radiolabelled Noradrenaline From Canine Blood Perfused Gracilis Muscle. Acta Physiol Scand 1984; 122 (4): 571-82.
21. Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G. Effects of Desipramine on Sympathetic Nerve Firing and Norepinephrine Spillover to Plasma in Humans. Am J Physiol 1991; 260 (4 Pt 2): R817-R823.
22. Jordan J, Shannon JR, Jacob G, Pohar B, Robertson D. Interaction of Genetic Predisposition and Environmental Factors in the Pathogenesis of Idiopathic Orthostatic Intolerance. Am J Med Sci 1999; 318 (5): 298-303.
23. Preiss G, Polosa C. Patterns of Sympathetic Neuron Activity Associated With Mayer Waves. Am J Physiol 1974; 226 (3): 724-30.
24. Furlan R, Porta A, Costa F, Tank J, Baker L, Schiavi R, Robertson D, Malliani A, Mosqueda-Garcia R. Oscillatory Patterns in Sympathetic Neural Discharge and Cardiovascular Variables During Orthostatic Stimulus. Circulation 29-2-2000; 101 (8): 886-92.
25. Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK. Central Sympathoinhibition and Peripheral Neuronal Uptake Blockade After Desipramine in Rabbits. Am J Physiol 1991; 260 (4 Pt 2): R824-R832.
26. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ. Plasma Dihydroxyphenylglycol and the Intraneuronal Disposition of Norepinephrine in Humans. J Clin Invest 1988; 81 (1): 213-20.
27. Jordan J, Knoblauch H, Tank J, Faulhaber HD, Luft FC, Busjahn A. Norepinephrine Transporter Gene and Blood Pressure Regulation in Normal Twins. (Abstract). Circulation 2000; 102 (Supplement-II): II-13.
28. Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Effects of Volume Loading and Pressor Agents in Idiopathic Orthostatic Tachycardia. Circulation 15-7-1997; 96 (2): 575-80.
29. Streeten DH. Pathogenesis of Hyperadrenergic Orthostatic Hypotension. Evidence of Disordered Venous Innervation Exclusively in the Lower Limbs. J Clin Invest 1990; 86 (5): 1582-8.
30. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, Suarez GA, Rummans TA. Postural Tachycardia Syndrome (POTS). Neurology 1995; 45 (4 Suppl 5): S19-S25.
31. Furlan R, Jacob G, Snell M, Robertson D, Porta A, Harris P, Mosqueda-Garcia R. Chronic Orthostatic Intolerance: a Disorder With Discordant Cardiac and Vascular Sympathetic Control. Circulation 17-11-1998; 98 (20): 2154-9.
32. Schondorf R, Low PA. Idiopathic Postural Orthostatic Tachycardia Syndrome: an Attenuated Form of Acute Pandysautonomia? Neurology 1993; 43 (1): 132-7.
33. Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Abnormal Norepinephrine Clearance and Adrenergic Receptor Sensitivity in Idiopathic Orthostatic Intolerance. Circulation 6-4-1999; 99 (13): 1706-12.
34. Shannon JR, Flattem NL, Jordan J, Jacob, G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic Intolerance and Tachycardia Associated With Norepinephrine-Transporter Deficiency. N Engl J Med 24-2-2000; 342(8): 541-9.
35. Jordan J, Shannon JR, Diedrich A., Black BK, Robertson D. Increased Sympathetic Activation in Idiopathic Orthostatic Intolerance: Role of Systemic Adrenoreceptor Sensitivity. Hypertension 2002; 39 (1): 173-8.
36. Bush VE, Wight VL, Brown CM, Hainsworth R. Vascular Responses to Orthostatic Stress in Patients With Postural Tachycardia Syndrome (POTS), in Patients With Low Orthostatic Tolerance, and in Asymptomatic Controls. Clin Auton Res 2000; 10 (5): 279-84.
37. Convertino VA, Polet JL, Engelke KA, Hoffler GW, Lane LD, Blomqvist CG. Evidence for Increased Beta-Adrenoreceptor Responsiveness Induced by 14 Days of Simulated Microgravity in Humans. Am J Physiol 1997; 273 (1 Pt 2): R93-R99.
38. Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, Ananthram V, Robertson RM, Robertson D. Sympathetic and Baroreceptor Reflex Function in Neurally Mediated Syncope Evoked by Tilt. J Clin Invest 1-6-1997; 99 (11): 2736-44.
39. Mosqueda-Garcia R, Fernandez-Violante R, Tank J, Snell M, Cunningham G, Furlan R. Yohimbine in Neurally Mediated Syncope. Pathophysiological Implications. J Clin Invest 15-11-1998; 102 (10):1824-30.
40. Davrath LR, Gotshall RW, Tucker A, Sadeh WZ, Luckasen GJ, Downes TR, Coonts CC. The Heart Is Not Necessarily Empty at Syncope. Aviat.Space Environ.Med 1999; 70 (3 Pt 1): 213-9.
41. Liu JE, Hahn RT, Stein KM, Markowitz SM, Okin PM, Devereux RB, Lerman BB. Left Ventricular Geometry and Function Preceding Neurally Mediated Syncope. Circulation 22-2-2000; 101 (7): 777-83.
42. Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG. Vasovagal Syncope After Infusion of a Vasodilator in a Heart-Transplant Recipient. N Engl J Med 1-3-1990; 322 (9): 602-4.
43. Wright C, Drinkhill MJ, Hainsworth R. Reflex Effects of Independent Stimulation of Coronary and Left Ventricular Mechanoreceptors in Anaesthetised Dogs. J Physiol 15-10-2000; 528 Pt 2: 349-58.